Key result
MINOCA carries ~30% lower 12-month mortality compared to MI-CAD.
Population
176,502 consecutive myocardial infarction patients who had coronary angiography performed, including pooled…
Design
Meta-analysis
Follow-up
12 months
Authors
Loading...
Clinicians should include MINOCA in MI differentials given its frequency and mortality; meta-analysis extends prior estimates with systematic pooling across large cohorts.
MINOCA accounts for approximately 6% of MI presentations and is associated with a lower but still guarded 12-month all-cause mortality (4.7%) compared to MI with obstructive CAD.
Pasupathy et al. (2015) studied this question. The prevalence of MINOCA was 6% with 12-month all-cause mortality at 4.7%, lower than the 6.7% for myocardial infarction with obstructive coronary artery disease.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: